45-2100001-2020 - usp-nf-online-2020-1-year-subscription-20-users-english

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Supplement 10.3 published in July 2020,<br>Supplement 10.4 published in October 2020 and<br>Supplement 10.5 published in January 2021.<br><br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Supplement 10.3 published in July 2020,<br>Supplement 10.4 published in October 2020 and<br>Supplement 10.5 published in January 2021.<br><br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>The subscription contains 3 issues in English:<br><br>Supplement 10.6 published in July 2021,<br>Supplement 10.7 published in October 2021 and<br>Supplement 10.8 published in January 2022.<br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 2025 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.6) and the first two supplements (11.7-11.8), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2025 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Supplement 11.6 published in July 2024,<br>Supplement 11.7 published in October 2024 and<br>Supplement 11.8 published in January 2025.<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>Online and downloadable access to Supplement 11.6 to Supplement 11.8.<br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2024 to the end of December 2025.<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.6) and two non-cumulative updates (11.7 and 11.8)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 2025 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.6) and the first two supplements (11.7-11.8), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2025 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Supplement 11.6 published in July 2024,<br>Supplement 11.7 published in October 2024 and<br>Supplement 11.8 published in January 2025.<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>Online and downloadable access to Supplement 11.6 to Supplement 11.8.<br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2024 to the end of December 2025.<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.6) and two non-cumulative updates (11.7 and 11.8)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 2025 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.6) and the first two supplements (11.7-11.8), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2025 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Supplement 11.6 published in July 2024,<br>Supplement 11.7 published in October 2024 and<br>Supplement 11.8 published in January 2025.<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>Online and downloadable access to Supplement 11.6 to Supplement 11.8.<br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2024 to the end of December 2025.<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.6) and two non-cumulative updates (11.7 and 11.8)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 2025 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.6) and the first two supplements (11.7-11.8), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2025 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Supplement 11.6 published in July 2024,<br>Supplement 11.7 published in October 2024 and<br>Supplement 11.8 published in January 2025.<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>Online and downloadable access to Supplement 11.6 to Supplement 11.8.<br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2024 to the end of December 2025.<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.6) and two non-cumulative updates (11.7 and 11.8)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>European Pharmacopoeia 2025 subscription:<br><br><br>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 11th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 11th Edition of the Ph. Eur. was released in July 2024 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8). <br><br>Main volume 11.6 published in July 2024,<br>Supplement 11.7 published in October 2024,<br>Supplement 11.8 published in January 2025.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 2025 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.6) and the first two supplements (11.7-11.8), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2025 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Supplement 11.6 published in July 2024,<br>Supplement 11.7 published in October 2024 and<br>Supplement 11.8 published in January 2025.<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>Online and downloadable access to Supplement 11.6 to Supplement 11.8.<br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2024 to the end of December 2025.<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.6) and two non-cumulative updates (11.7 and 11.8)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>EUROPEAN PHARMACOPOEIA 12th EDITION<br> <br>European Pharmacopoeia - Individual licence - Bilingual<br><br>As from the 12th Edition:<br>The European Pharmacopoeia is moving to an online-only format.<br>New publication cycle: each edition will comprise three issues published over a 12 month period (e.g. 12,1, 12,2, 12.3)<br>New 365-days licences (from the activation day of the licence key) with an access to all texts (current, future and archives).<br><br>This licence will grant access to all texts (past, current and future) for 365 days from the activation date.<br><br>Note: for orders placed in May and June 2025, licence keys (EPID) will be sent in July (at the latest).<br><br>Languages: bilingual (English &amp; French).<br><br>ISBN: 978-92-871-9611-8<br><br>The former three-year cycle comprising one edition and eight supplements will be replaced by an annual edition made up of three issues, numbered .1 to .3 (for example, the 12th Edition will consist of Issues 12.1, 12.2 and 12.3). Each of these issues will contain the new and revised texts adopted at one of the three European Pharmacopoeia Commission (EPC) sessions held annually. What will not change is the implementation schedule, which remains January, April and July, respectively, of the year following publication of a text. A detailed calendar presenting the EPC sessions and adoption and implementation dates will be published in due time.<br><br>All subscriptions to the 11th Edition will remain valid during the transitional period until the end of 2025. As of 1 January 2026, users will only be able to subscribe to the online version. </p>

<p>Joint and Paediatric Formulary Committees<br><br>Scheduled closure of pharmpress.com<br><br>Published jointly by the British Medical Association, the Royal Pharmaceutical Society, the Royal College of Paediatrics and Child Health, and the Neonatal and Paediatric Pharmacists Group.<br><br>Product code BNF_CY1<br><br>BNF &amp; BNFC 1 Year Subscription<br><br><br>DESCRIPTION:<br><br> Access to the BNF and British National Formulary for Children is vital for all healthcare and pharmacy professionals, providing practical guidance on prescribing, dispensing, and administering medicines.<br>To help keep you up-to-date, print copies of these essential publications are now available via subscription, meaning you get the latest medicines information as it is published and for a reduced price.<br> Subscription option Subscription price Saving on RRP BNF + BNFC subscription for 1 year £165.00 21% Also available: <br> <a href=" target="_blank" rel="noreferrer noopener"> <br> <br> </p>

<p>Joint and Paediatric Formulary Committees<br><br>Scheduled closure of pharmpress.com<br><br>Published jointly by the British Medical Association, the Royal Pharmaceutical Society, the Royal College of Paediatrics and Child Health, and the Neonatal and Paediatric Pharmacists Group.<br><br>Product code BNF_CY2<br><br>BNF &amp; BNFC 2 Year Subscription<br><br><br>DESCRIPTION:<br><br> Access to the BNF and British National Formulary for Children is vital for all healthcare and pharmacy professionals, providing practical guidance on prescribing, dispensing, and administering medicines.<br>To help keep you up-to-date, print copies of these essential publications are now available via subscription, meaning you get the latest medicines information as it is published and for a reduced price.<br> Subscription option Subscription price Saving on RRP BNF + BNFC subscription for 2 years £310.00 24% <br> Also available: <br> BNF + BNFC subscription for 1 year <br> <br>CONTENTS:<br><br>This essential resource provides up-to-date, practical guidance on prescribing, dispensing, and administering medicines. <br>The BNF evaluates clinical evidence from diverse sources with information validated by a network of clinical experts and published under the authority of a Joint Formulary Committee. The BNF reflects current best practice as well as legal and professional guidelines relating to the uses of medicines. Includes: <br> - Guidance on the drug management of common conditions <br> - Details of medicines prescribed within the UK with special reference to their uses, cautions, contra-indications, side-effects, doses and relative costs <br> - Guidance on prescribing, monitoring, dispensing and administering medicines <br> <br> </p>

<p>Joint Formulary Committee<br><br>Scheduled closure of pharmpress.com<br><br>Published jointly by the British Medical Association and the Royal Pharmaceutical Society<br><br>Product code BNFY1<br><br>BNF 1 Year Subscription<br><br><br>DESCRIPTION:<br><br> Access to the BNF (British National Formulary) is vital for all healthcare and pharmacy professionals, providing practical guidance on prescribing, dispensing, and administering medicines. <br> To help keep you up-to-date, print copies of this essential publication are now available via subscription, meaning you get the latest medicines information as it is published and for a reduced price. <br> Subscription option Subscription price Saving on RRP BNF subscription for 1 year £113.00 20% Also available:<br> Single issue of the print BNF <br> BNF subscription for 2 years <br> BNF + BNFC subscription for 1 year <br> BNF + BNFC subscription for 2 years <br> <br>CONTENTS:<br><br> This essential resource provides up-to-date, practical guidance on prescribing, dispensing, and administering medicines.<br> The BNF evaluates clinical evidence from diverse sources with information validated by a network of clinical experts and published under the authority of a Joint Formulary Committee. The BNF reflects current best practice as well as legal and professional guidelines relating to the uses of medicines. Includes:<br> - Guidance on the drug management of common conditions<br> - Details of medicines prescribed within the UK with special reference to their uses, cautions, contra-indications, side-effects, doses and relative costs<br> - Guidance on prescribing, monitoring, dispensing and adminstering medicines <br> <br> </p>

<p>Joint Formulary Committee<br><br>Scheduled closure of pharmpress.com<br><br>Published jointly by the British Medical Association and the Royal Pharmaceutical Society<br><br>Product code BNFY2<br><br>BNF 2 Year Subscription<br><br><br>DESCRIPTION:<br><br> Access to the BNF is vital for all healthcare and pharmacy professionals, providing practical guidance on prescribing, dispensing, and administering medicines.<br>To help keep you up-to-date, print copies of this essential publication is now available via subscription, meaning you get the latest medicines information as it is published and for a reduced price.<br> Subscription option Subscription price Saving on RRP BNF subscription for 2 years £210.00 26% <br> Also available: <br> BNF subscription for 1 year <br> BNF + BNFC subscription for 1 year <br> BNF + BNFC subscription for 2 years <br> <br>CONTENTS:<br><br> This essential resource provides up-to-date, practical guidance on prescribing, dispensing, and administering medicines.<br> The BNF evaluates clinical evidence from diverse sources with information validated by a network of clinical experts and published under the authority of a Joint Formulary Committee. The BNF reflects current best practice as well as legal and professional guidelines relating to the uses of medicines. Includes:<br> - Guidance on the drug management of common conditions<br> - Details of medicines prescribed within the UK with special reference to their uses, cautions, contra-indications, side-effects, doses and relative costs<br> - Guidance on prescribing, monitoring, dispensing and adminstering medicines <br> <br> </p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Main volume 10.0 published in July 2019,<br>Supplement 10.1 published in October 2019,<br>Supplement 10.2 published in January 2020.<br><br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.<br></p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Main volume 10.0 published in July 2019,<br>Supplement 10.1 published in October 2019,<br>Supplement 10.2 published in January 2020.<br><br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Main volume 10.0 published in July 2019,<br>Supplement 10.1 published in October 2019,<br>Supplement 10.2 published in January 2020.<br><br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Supplement 10.3 published in July 2020,<br>Supplement 10.4 published in October 2020 and<br>Supplement 10.5 published in January 2021.<br><br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.</p>

<p>(Available in 2022)<br><br>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br><br>The subscription contains 3 issues in English:<br><br>Supplement 10.6 published in July 2021,<br>Supplement 10.7 published in October 2021 and<br>Supplement 10.8 published in January 2022.<br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>TThe 2023 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.0) and the first two supplements (11.1-11.2), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2023 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>access, in English and French, until 31 December 2023 to the content of the initial release (11.0) and two cumulative updates (11.1 and 11.2)<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.0) and two non-cumulative updates (11.1 and 11.2)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>